title: Response to 'In-utero exposure to tenofovir is associated with impaired fetal and infant growth' by Denneman et al.
authors.affiliation: aDivision of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa bICAP, Columbia University Mailman School of Public Health cCollege of Physicians and Surgeons, Columbia University dDepartment of Medicine; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York City, New York, USA eCentre for Infectious Diseases Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
authors.forename: Stanzi M
authors.initials: SM
authors.lastname: le Roux
authors.forename: Elaine J
authors.initials: EJ
authors.lastname: Abrams
authors.forename: Jennifer
authors.initials: J
authors.lastname: Jao
authors.forename: Thoko
authors.initials: T
authors.lastname: Malaba
authors.forename: Landon
authors.initials: L
authors.lastname: Myer
mesh_terms: D019380:Anti-HIV Agents; D005260:Female; D015658:HIV Infections; D006801:Humans; D007223:Infant; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011295:Prenatal Care; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D000068698:Tenofovir